When following COVID-19 research, it’s hard to keep your eye on the ball...

How can we best deliver solubility-challenged small molecules to the clinic?

How can companies avoid the risks of HPAPI containment and handling?

Can machine learning offer mass spectrometry a boost for drug discovery?

Power testing partnership, NASH breakthrough designation, and new CEO appointments. What’s new for pharma in business?

Sitting Down With... Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia.

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Exploring a new approach to treating IBS pain.

In what ways can the microbiome interact with oral medicines?

QC must evolve to meet progress in biopharmaceutical manufacturing.